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Abstract
The human umbilical vein, as a readily available stem cell source, is a good alternative to har-
vest mesenchymal stem cells. Human umbilical cord vein mesenchymal stem cells have recent-
ly been isolated and have demonstrated the ability to differentiate into various cell types such 
as fat, bone, cartilage and neuronal cells. In this study, we have investigated whether human 
umbilical cord vein mesenchymal stem cells are also able to differentiate into hepatocyte-like 
cells. Hepatic differentiation was performed with a 2-step protocol and the use of hepatocyte 
growth factor and oncostatin M for cell culture. During four weeks of induction, most cells 
displayed a cuboidal morphology. Immunological analysis indicated that umbilical cord vein 
mesenchymal stem cells-derived hepatocyte-like cells expressed liver-specific protein markers 
such as albumin and cytokeratin-18. The hepatocyte-like cells also displayed several character-
istics of hepatocytes, including expression of transthyretin, glucose 6-phosphatase, cytokera-
tin-8,18, alpha-fetoprotein, hepatocyte nuclear factor-3β and albumin. The result of indocya-
nine green cell uptake, as a test substance to evaluate hepatocyte-like cell function, was posi-
tive for differentiated cells. Glycogen storage was examined by periodic acid-Schiff staining. 
Accumulation of intracellular glycogen was detected in the hepatocyte-like cells. Based on 
these observations, we have concluded that umbilical cord vein mesenchymal stem cells are 
endowed with hepatogenic potential and may provide a stem cell source to be used as cell 
therapy for liver diseases.
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Introduction
Mesenchymal stem cells (MSCs) are a group of clonogenic cells present among 
the bone marrow (BM) stroma that are capable of multilineage differentiation into 
various cell types of mesodermal origin (Deans and Moseley, 2000). MSCs can be 
obtained from BM (Friedenstein and el al., 1974), amniotic fluid (Anker and Scher-
jon, 2003), cord blood (Lee O.K. et al., 2004) placenta and other different tissue sourc-
es (Hans et al., 2008). Recently, instead of using cord blood, Romanov et al. (2003) 
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and Covas et al. (2003) have been able to obtain MSCs from cells detached from the 
umbilical vein. Recently, we have shown the expression of several self-renewal reg-
ulator genes as well as SSEA-4, an embryonic stem cell surface marker, in human 
umbilical cord vein mesenchymal stem cells (UVMSCs) (Kermani et al. 2008). In spite 
of many similarities, human MSCs from different origins don’t show similar differen-
tiation potential, but there is the growing interest in using these differently sourced 
cells in regenerative medicine (Augello et al., 2007; Gerdoni et al., 2007; Martin-Ren-
don et al., 2008).
Researchers have considered the plausible use of stem cells for treating liver dis-
eases (Fox et al., 1998). Although the liver has a high proliferative power, many dis-
eases can damage its regenerative potential. Recently, researchers have considered 
the possibility of producing hepatocytes from different stem cell sources. Various 
studies have investigated the differentiation ability of stem cells to liver cells with 
the use of embryonic stem cells (Baharvand et al., 2006), hepatic stem cells (Golding 
et al., 1995), a mononuclear cell fraction of BM (Petersen et al., 1999), multipotent 
adult progenitor cells (Schwartz et al., 2002) and hematopoietic stem cells (Lagasse 
et al., 2000).
Here we report the capability of UVMSCs to differentiate into functional hepato-
cyte-like cells in vitro.
Materials and methods
Isolation and culture of UVMSCs
Isolation of UVMSCs was performed as previously described. Briefly, human 
umbilical cords were obtained after normal term deliveries of healthy infants and 
brought to the laboratory in Hank’s balanced salt solution (HBSS, Gibco, Paisley, 
United Kingdom) that contained 300 U/mL penicillin, 300 µg/mL streptomycin, 
150 µg/mL gentamicin, and 1 µg/mL Fungizone. Cords were processed within 6–12 
h. After disinfection in 75% ethanol for 30 s, the umbilical cord veins were washed 
twice with HBSS that contained 100 U/mL heparin. The distal ends were clamped 
and veins were filled with 0.1% collagenase type IV (Sigma, St. Louis, MO). After 
clamping the proximal ends, umbilical cords were incubated at 37°C for 20 min. 
Veins were washed with phosphate buffered saline (PBS; Gibco) and isolated cells 
were collected and cultured in low-glucose DMEM (Dulbecco’s modified Eagle’s 
medium-low glucose) supplemented with 10 ng/mL epidermal growth factor (EGF; 
Sigma), 20 ng/mL basic fibroblastic growth factor (bFGF; Sigma), 15% fetal bovine 
serum (FBS; Gibco), 100 U/mL penicillin (Gibco), and 100 µg/mL streptomycin (Gib-
co). UVMSCs were isolated by their ability to adhere to a plastic surface.
Passage 5 UVMSCs were allowed to differentiate for 28 days in differentiation 
medium, which was changed every three days. Differentiated UVMSCs were disso-
ciated with 0.05% trypsin and 0.04% ethylenediaminetetraacetic acid (EDTA; Gibco, 
Brl, Berlin, Germany) for 5 min, centrifuged, and replated in differentiation medium 
in 3 cm tissue culture dishes. They were grown to confluence, serially passaged, and 
expanded in differentiation medium.
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Culture of HepG2 cells
Human hepatoma cell line, HepG2, was obtained from Pasteur Institute, Tehran, 
Iran and cultured in RPMI medium (Roswell Park Memorial Institute medium) sup-
plemented with 10% FBS. We used this cell line as a positive control for differentiated 
hepatocyte-like cell analysis.
Hepatic differentiation of UVMSCs
Hepatic differentiation was performed by using a 2-step protocol with sequential 
addition of growth factors and cytokines. Cells in passage 5 were plated on fibronec-
tin-coated dishes at a density of 1.5×104 cells/cm2 in DMEM-LG (Invitrogen, Carls-
bad, California) supplemented with 15% FBS, 20 ng/mL bFGF, 10 ng/mL EGF and 
grown to 60%-80% confluence. Cells were treated with initiation medium for two 
weeks that contained proliferative medium supplemented with 0.5 μmol/l dexameth-
asone (Sigma), 1x ITS+ Premix (BD Biosciences), 50 ng/mL hepatocyte growth factor 
(HGF; R&D Systems, Minneapolis, MN), 10 ng/mL EGF, and 20 ng/mL bFGF. Initia-
tion medium was replaced by maturation medium for another two weeks. Matura-
tion medium consisted of proliferative medium and contained 0.5 μmol/l dexameth-
asone, 10 ng/mL EGF, 20 ng/mL bFGF, 1x ITS+ Premix and 50 ng/mL oncostatin M 
(OSM, Sigma). Differentiated liver-like cells were subcultured every four to five days 
until the end of experiment.
RNA extraction and RT-PCR analysis
Total RNA was isolated using the RNX plus Kit (CinnaGen, Tehran, Iran), 
according to the manufacturer’s recommendations. One µg of total RNA was 
reverse transcribed into DNA using AMV reverse transcriptase and a random hex-
amer primer (RT-PCR Kit; Bioneer, Daejeon, South Korea). RT-PCR was performed 
in a 50 µl reaction mixture using a thermal cycler (Mastercycler; Eppendorf, Ham-
burg, Germany). cDNA was then subjected to PCR amplification with a PCR kit 
(Bioneer) and primer sets that were specific to the genes of interest (Table 1). The 
PCR conditions were initial denaturation for 5 min at 94°C followed by 35 cycles 
of denaturation for 30 s at 94°C, annealing for 45 s at 53-58°C (depending on prim-
ers) and extension for 60 s at 72°C. The reaction was followed by a final extension 
step for 10 min at 72°C. The expression of beta-2 microglobulin mRNA, a constitu-
tively and ubiquitously expressed gene, served as an internal control in all RT-PCR 
reactions. The PCR products were separated on a 1% agarose gel electrophoresis, 
stained with ethidium bromide, visualized and photographed on a UV transillumi-
nator (Uvidoc, Cambridge, UK).
Immunofluorescence analysis
Cells were washed with PBS and fixed with 4% paraformaldehyde for 20 min at 
room temperature. Fixed cells were permeabilized and blocked for 45 min in PBS that 
contained 0.01% Triton X-100 (Sigma) and 10% serum. Then differentiated cells were 
incubated with mouse monoclonal anti-albumin (anti-ALB, 1:50, R&D Systems) and 
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rabbit monoclonal anti-cytokeratin (CK) 18 (1:50; Santa Cruz Biotechnology, Santa 
Cruz, CA) overnight at 4ºC. The samples were then incubated for 45 min at 37ºC with 
FITC-conjugated secondary antibody against mouse (for ALB, 1:100; Abcam, Cam-
bridge, UK) or TRITC-conjugated secondary antibody against rabbit (for CK-18, 1:100; 
Abcam). PBS-containing serum was used for washing the specimens between anti-
body incubations. Cover slips were mounted in mounting medium and immediately 
examined under an inverted fluorescent microscope (TE-300; Nikon, Tokyo, Japan).
Indocyanine green cellular uptake analysis
Indocyanine green (ICG, Acros Organics, Geel, Belgium) was added to the cell 
culture media of differentiated, undifferentiated and positive control cells at a final 
concentration of 1 mg/mL. Cells were incubated at 37°C for 30 min and then rinsed 
with PBS. After the dish was rinsed three times with PBS, the cellular uptake of ICG 
was examined by an inverted microscope.
Periodic acid Schiff (PAS) staining
Glycogen storage in the fixed, differentiated cells was examined using period-
ic acid-Schiff (PAS, Sigma) staining. The cells were oxidized in 1% periodic acid for 
Gene Primer Sequence (5’ - 3’) Length (bp) 
Gene 
bank code 








F: GTTTCATCCATCCGACATTG 199 NM_004048 
Cytokeratin-18 (CK-18) 
R: ACAGTCTGCTGAGGTTGGA 
F: CAGACACCACTTTGCCATC 412 NM_000224 
Cytokeratin-8 (CK-8) 
R: TGCCTCTACCATGTCCATCA 




F: GCTGAATGTCTGTCTGTCACGAA 494 NM_000151 
Hepatocyte growth 
factor receptor (c-Met) 
R: TGTGTTGTCCCGTGGCCATTTG 
F: TGCGATCGGAGGAATGCCTGAG 307 NM_000245 
Hepatocyte nuclear 
factor- 3β (HNF3β) 
R: TGCAACACCGTCTCCCCAAAGT 
F: CCACCACCAACCCCACAAAATG 294 NM_021784 
Transthyretin (TTR) R: GTGACGACAGCCGTGGTGGAA F: GGTGAATCCAAGTGTCCTCTGAT 352 NM_000371 
Table 1 – Primers and PCR conditions for RT-PCR analysis of hepatocyte-like cells differentiated from 
UVMSCs.
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10 min and rinsed three times in distilled H2O. Afterwards, cells were treated with 
Schiff’s reagent for 10 min, rinsed in distilled H2O for 10 min, and observed under a 
microscope.
DiI uptake staining
After four weeks, differentiated cells were incubated in culture maturation medi-
um that contained 20 ug/mL DiI-Ac-LDL (acetylated low density lipoprotein, labeled 
with 1,1’-dioctadecyl-3,3,3’,3’-tetramethyl-indocarbocyanine perchlorate; Invitrogen) 
for 24 h at 37°C. Cells were fixed with 2% formaldehyde in PBS. After washing with 
PBS, cells were then washed with fresh PBS, further incubated in 20 mg/mL DAPI. 
Incorporation of fluorochrome-labeled LDL and DAPI was estimated in a fluorescent 
microscope (IX-71, Olympus, Tokyo, Japan) with a Texas-Red filter.
Results
Morphological changes in UVMSCs-derived hepatocyte-like cells
Human umbilical vein MSCs were expanded for at least 20 passages. Passage 5 
UVMSCs were used for differentiation. The proliferative rate of differentiated cells 
gradually decreased.
During the first two weeks, UVMSCs in the presence of initiation medium for dif-
ferentiation lost their fibroblastic aspect (Fig. 1A) and became broad and flat (Fig. 1C). 
Abundant granules appeared in the cytoplasm of UVMSCs-derived hepatocyte-like 
cell (Fig. 1D), which we did not see in undifferentiated cells (Fig. 1B). During the 
Figure 1 – Changes in cell morphology during hepatic differentiation of UVMSCs. Cultured undifferentiated 
cells (A, B) differentiated into round, oval or polygonal cells (C, D) upon hepatogenic condition. A, C: 100x; B, 
D: 400x.
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third and fourth weeks of differentiation, in the presence of OSM, differentiating cells 
developed a cuboidal morphology characteristic for hepatic cells.
Expression profile of hepatocyte-specific genes in differentiating hepatocytes 
The mRNA expression pattern of hepatocyte-specific genes was analyzed by 
reverse-transcription polymerase chain reaction (RT-PCR; Fig. 2). RT-PCR analysis 
showed the expressions of ALB by day 7, glucose 6-phosphatase (G6P) by day 14, 
c-Met and transthyretin (TTR) by day 28. Expressions of CK-8 and CK-18, hepato-
cyte nuclear factor-3β (HFN3β) and tyrosine aminotransferase were detected during 
differentiation at all time points and gradually increased. Alpha-fetoprotein (AFP) 
expression was detected only at day 14 of the experiment. Undifferentiated cells did 
not express ALB, G6P, TTR, c-Met nor AFP but did express low levels of CK-8 and 
CK-18 and HFN3β. HepG2 cells were used as positive controls.
IF analysis of hepatic protein expression 
To further confirm the differentiation of UVMSCs into hepatocytes, we examined 
ALB and CK-18 expressions by immunofluorescence analysis. The differentiated cells 
stained positively for these markers (Fig. 3).
Glycogen storage as detected by PAS staining
Glycogen was detected by PAS staining in hepatocyte-like cells. Undifferentiated 
cells were negative with this staining (Fig. 4). 
Figure 2 – RT-PCR analyses of the expression pattern of hepatocyte-specific markers during hepatic differ-
entiation of UVMSCs. CK8: cytokeratin 8; ALB = albumin; CK18 = cytokeratin 18; HFN3B = hepatocyte nucle-
ar factor-3β; TTR = transthyretin; TAT = tyrosine aminotransferase; AFP = alpha-fetoprotein; G6P = glucose 
6-phosphatase; c-met = c-Met; B2m = β2-microglobulin. Expression of alpha-fetoprotein was noted only at 
the second week of induction.
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Figure 3 – Immunocytochemistry of differentiated UVMSCs into hepatocyte-like cells stained with anti-albu-
min and anti-cytokeratin-18 antibodies. (A, C) UVMSCs-derived hepatocyte-like cells stained for albumin and 
cytokeratin-18, respectively. (B, D) HepG2 cells were used as positive control. E-H show the phase contrast 
counterparts of A-D, respectively. 200x.
Figure 4 – Cellular uptake of indocyanine green, and glycogen storage as determined by periodic acid-Schiff 
staining. (A) Undifferentiated UVMSCs cells were negative for indocyanine green. (B) Most differentiated cells 
were positive for indocyanine green. (D) Undifferentiated UVMSCs cells were periodic acid-Schiff negative. (E) 
Differentiated UVMSCs cells displayed glycogen granules. (C,F) In both experiments, the HepG2 cell line was 
used as positive controls. 200x.
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Analysis of ICG and LDL uptake 
Since ICG is clinically used as a test substance to evaluate liver function because it 
is eliminated exclusively by hepatocytes, we first examined the cellular uptake of ICG 
in a HepG2 cell line. HepG2 cells were positive for ICG, while undifferentiated cells 
were negative. Differentiated hepatocyte-like cells were positive for ICG. 
Immunofluorescence analysis indicated that undifferentiated cells were unable to 
incorporate acetylated LDL, however approximately 50% of the cells that were treat-
ed for two weeks with initiation medium and another two weeks with maturation 
medium were able to incorporate it (Fig. 5).
Discussion
Umbilical VMSCs, as an attractive source of stem cells, were first isolated in the 
year 2003 (Covas et al., 2003; Romanov et al., 2003). These stem cells have the capa-
bility to differentiate into mesodermal and ectodermal lineage cells, including adipo-
cytes, osteoblasts, chondrocytes, neurons, astrocytes and cardiomyocytes (Covas et 
al., 2003; Romanov et al., 2003; Kadivar et al., 2006a,b). 
Recently we isolated human UVMSCs and characterized the isolated cells by eval-
uating the expression of certain embryonic stem cell surface markers as well as some 
major embryonic and adult stem cell self-renewal regulatory genes. We have shown 
that several self-renewal regulatory genes as well as SSEA-4, an embryonic stem cell 
surface marker, are expressed in UVMSCs (Kermani et al., 2008).
In this study, we investigated the hepatic differentiation of UVMSCs cells. To opti-
mize hepatocyte formation, many different conditions were tested. We pre-incubated 
Figure 5 – LDL uptake by UVMSC-derived hepatocytes. Hepatic differentiation was performed with a 2-step 
protocol and the use of hepatocyte growth factor and oncostatin M. Differentiated cells were incubated with 
DiI-acil-LDL, fixed, and visualized with an inverted fluorescent microscope. Representative immunofluores-
cence micrographs are shown for undifferentiated (A, week 0) and differentiated cells (B, 4 weeks). DiI-Ac-
LDL and DAPI are shown as red and blue colors, respectively. 200x.
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the cells in serum and/or growth factor-free (EGF, bFGF) medium however the cells 
either died or underwent spontaneous differentiation into neural-like cells. When 
UVMSCs were plated at 15,000 cell/cm2 and grown to 60% to 80% confluence, they 
differentiated into hepatocyte-like cells, whereas UVMSCs plated and treated at lower 
cell density died.
We also treated the cells with a 25 ng/mL concentration of HGF and OSM in 
both initiation and maturation media. Morphological and RT-PCR results indicated 
that the higher concentrations of HGF and OSM indeed used were required for opti-
mal triggering of hepatogenic signal transduction systems. Finally, UVMSCs were 
cultured on fibronectin-coated dishes with proliferation medium and differentiated 
into hepatocyte-like cells by using a 2-step differentiation protocol with sequential 
addition of HGF, OSM and hormones (dexamethasone and insulin). mRNA expres-
sion of endodermal and hepatocyte-specific genes that included TTR, G6P, CK-8,18, 
AFP, hepatocyte nuclear factor-3β (HNF3β) and ALB was detected at varying stag-
es of UVMSC differentiation. Differentiated cells were found to store glycogen and 
uptake ICG, which indicated the differentiation of UVMSCs into functional hepato-
cyte-like cells.
Hong et al. have differentiated umbilical cord blood derived MSCs into hepato-
cytes with the same protocol as the current study, and reported similar results (Hong 
et al., 2005).
Zhao et al. (2009) have recently reported in vitro transdifferentiation of umbilical 
cord MSCs into a hepatic lineage by using a modified 2-step induction protocol. In 
their study, high expressions of hepatic markers AFP and ALB were accompanied by 
increased production of ALB and urea in supernatant in a time-dependent manner.
Schwartz et al. (2002) have analyzed the capability of multipotent adult progeni-
tor cells to differentiate into hepatocytes. They reported the necessity of a high cell 
density for hepatic differentiation. The results of this study in conjunction with those 
of Schwartz et al. (2002) and Hong et al. (2005) have suggested that cell–cell contact is 
an important factor in the hepatic differentiation process.
Talens-Visconti et al. (2006) have induced hepatic differentiation of human MSCs 
from adipose tissue and from BM. In their studies, cells were serum deprived for 
two days, pre-cultured in medium supplemented with growth factors, followed by a 
2-step differentiation protocol and subsequently by the sequential addition of growth 
factors, cytokines and hormones. The 2-step differentiation protocol in their study 
has previously been used for hepatic differentiation of human BM MSCs (Lee K.D. et 
al., 2004).
The expression profile of hepatic-specific genes examined in our study compared 
with the study conducted by Hong et al. (2005) has shown that, as in that study, the 
level of expression for ALB and CK-18 genes gradually increased during the course 
of the experiment. TAT gene expression was observed in the whole study period of 
this experiment and to a lesser degree in undifferentiated cells. However, in the study 
by Hong et al. (2005) TAT gene expression was observed only during the third and 
fourth weeks of the experiment. In our study, c-Met gene expression was observed 
in the second to fourth weeks whereas in the Hong et al. (2005) study c-Met gene 
expression was observed only in the third and fourth weeks.
Both in this study and in a study by Lee K.D. et al. (2004) the expressions of 
ALB, CK-18 and G6P were detected on days 14 and 28. However, expression of TAT 
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in their study was seen at day 28, whereas in the current study TAT expression was 
seen in the whole study period of this experiment. The expression of AFP gene in this 
study was noted only on day 14, but in the above mentioned study it was seen at 
days 14 and 28.
All these findings suggest that MSCs derived from different tissue sources do not 
exhibit the same behavior during hepatic differentiation. This suggestion is in line 
with a report which demonstrated that human MSCs derived from five different tis-
sues exhibit different differentiation potentials as manifested by the rate of differen-
tiation and percentage of differentiated cells (Musina et al., 2006).
Because MSCs have the ability to differentiate into three lineages, these stem cells 
have been considered as an attractive source for tissue engineering and stem cell 
therapy (Romanov et al., 2003). However the number of MSCs significantly decreases 
with age (Rao et al., 2001; Romanov et al., 2003). It has been reported that BM-MSCs 
are permissive to productive HCMV infection, and that HCMV alters the function of 
MSCs (Smirnov et al., 2007). Sundin et al. (2006) have reported that MSCs may be 
susceptible to infection if infused in a patient with CMV or HSV-1 viremia.
Although umbilical cord blood is a rich source of hematopoietic stem/progenitor 
cells useful for clinical applications (Huss 2000; Hows 2001; Romanov et al., 2003), 
attempts to isolate MSCs from that blood have not always been successful (Hong et 
al., 2005).
Our results indicate that UVMSCs can differentiate into hepatocyte-like cells. In 
conclusion, the umbilical cord vein might be an easily accessible source for multi-
potent stem cells that are capable of differentiating toward hepatocyte-like cells in 
vitro.
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